Hepion PharmaceuticalsHEPA

13F holders, Q3 2024 (September 30)
22holders −2
3new positions
4sold out
2famous investors
$0.62avg. 13F price*

At the end of Q3 2024, 22 institutions reported holding Hepion Pharmaceuticals Inc. (HEPA) in their 13F filings, down 2 from Q2 2024. 3 opened new positions and 4 sold out. The largest holders were Anson Funds Management LP ($128K), Vanguard Group Inc. ($61K) and BlackRock, Inc. ($56K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Hepion Pharmaceuticals Inc.
CUSIP
426897302
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q1 2024: 25Q1 2024Q2 2024: 24Q2 2024Q3 2024: 22Q3 2024Q4 2024: 22Q4 2024Q2 2025: 1Q2 2025Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions3$159K
Exits4$552K

All 13F filers, Q2 2024 → Q3 2024: 281,248 shares bought and 577,588 shares sold, net −296,340 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 22 holders

Anson Funds Management LP 0.02% New 231,849 $128K
Vanguard Group Inc. 0.00% Reduce -28.8% 90,922 $61K
BlackRock, Inc. 0.00% — 82,954 $56K
Geode Capital Management, LLC 0.00% Add +5.6% 47,026 $32K
Citadel Advisors 0.00% New 29,307 $20K
Renaissance Technologies 0.00% New 16,564 $11K
State Street Corp. 0.00% No change 15,676 $11K
Susquehanna International Group, LLP 0.00% Add +0.0% 14,640 $10K
PNC Financial Services Group, Inc. 0.00% No change 7,724 $5K
Tower Research Capital LLC (TRC) 0.00% Add +17.9% 6,847 $5K
Morgan Stanley 0.00% No change 1,357 $909
Federation des caisses Desjardins du Quebec 0.00% No change 175 $117
Osaic Holdings, Inc. 0.00% No change 113 $75
Group One Trading LLC 0.00% No change 84 $56
AdvisorNet Financial, Inc 0.00% Reduce -28.4% 63 $42
Bank of America Corp. 0.00% Add +4.3% 48 $32
Barclays PLC 0.00% No change 16 $11
UBS Group AG 0.00% Reduce -95.7% 3 $2
Signaturefd, LLC 0.00% No change 1 $1
Harbor Investment Advisory, LLC 0.00% No change 1 $1
Allworth Financial LP 0.00% No change 1 $1
Global Retirement Partners, LLC 0.00% No change 1 $1

"% of holder's portfolio" is HEPA's weight in each manager's 13F, not the share of Hepion Pharmaceuticals Inc. the manager owns.